205 related articles for article (PubMed ID: 31728688)
1. Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
Reinert CP; Sekler J; la Fougère C; Pfannenberg C; Gatidis S
Eur Radiol; 2020 Mar; 30(3):1325-1333. PubMed ID: 31728688
[TBL] [Abstract][Full Text] [Related]
2. Impact of PET/CT on management of patients with esophageal cancer - results from a PET/CT registry study.
Reinert CP; Sekler J; Gani C; Nikolaou K; la Fougère C; Pfannenberg C; Gatidis S
Eur J Radiol; 2021 Mar; 136():109524. PubMed ID: 33434862
[TBL] [Abstract][Full Text] [Related]
3. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
4. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H
J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990
[TBL] [Abstract][Full Text] [Related]
5. Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
Subramaniam RM; Shields AF; Sachedina A; Hanna L; Duan F; Siegel BA; Hillner BE
Oncologist; 2016 Sep; 21(9):1079-84. PubMed ID: 27401896
[TBL] [Abstract][Full Text] [Related]
6. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
[TBL] [Abstract][Full Text] [Related]
7. The added value of
Kazmierczak PM; Rominger A; Wenter V; Spitzweg C; Auernhammer C; Angele MK; Rist C; Cyran CC
Eur Radiol; 2017 Apr; 27(4):1676-1684. PubMed ID: 27436022
[TBL] [Abstract][Full Text] [Related]
8. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Walter F; Cloughesy T; Walter MA; Lai A; Nghiemphu P; Wagle N; Fueger B; Satyamurthy N; Phelps ME; Czernin J
J Nucl Med; 2012 Mar; 53(3):393-8. PubMed ID: 22323780
[TBL] [Abstract][Full Text] [Related]
9. Practice-based evidence for the clinical benefit of PET/CT-results of the first oncologic PET/CT registry in Germany.
Pfannenberg C; Gueckel B; Wang L; Gatidis S; Olthof SC; Vach W; Reimold M; la Fougere C; Nikolaou K; Martus P
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):54-64. PubMed ID: 30269155
[TBL] [Abstract][Full Text] [Related]
10. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
11. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
[TBL] [Abstract][Full Text] [Related]
12. Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis.
De Dosso S; Treglia G; Pascale M; Tamburello A; Santhanam P; Kroiss AS; Pereira Mestre R; Saletti P; Giovanella L
Endocrine; 2019 Jun; 64(3):456-468. PubMed ID: 31004334
[TBL] [Abstract][Full Text] [Related]
13. Most of the Intended Management Changes After
Calais J; Czernin J; Eiber M; Fendler WP; Gartmann J; Heaney AP; Hendifar AE; Pisegna JR; Hecht JR; Wolin EM; Slavik R; Gupta P; Quon A; Schiepers C; Allen-Auerbach MS; Herrmann K
J Nucl Med; 2017 Nov; 58(11):1793-1796. PubMed ID: 28473600
[TBL] [Abstract][Full Text] [Related]
14. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Viganò L; Lopci E; Costa G; Rodari M; Poretti D; Pedicini V; Solbiati L; Chiti A; Torzilli G
Ann Surg Oncol; 2017 Apr; 24(4):1029-1036. PubMed ID: 27807727
[TBL] [Abstract][Full Text] [Related]
15. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
16. The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Lu P; Sun Y; Sun Y; Yu L
Lung Cancer; 2014 Jul; 85(1):53-8. PubMed ID: 24792334
[TBL] [Abstract][Full Text] [Related]
17. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
18. [Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
de Guevara DL; Fuentes A; Fariña C; Corral C; Pefaur R
Rev Med Chil; 2013 Jan; 141(1):41-8. PubMed ID: 23732413
[TBL] [Abstract][Full Text] [Related]
19. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
